Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) CFO Sells 5,198 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 5,198 shares of USANA Health Sciences stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

USANA Health Sciences Stock Performance

NYSE:USNA traded up $0.12 during midday trading on Tuesday, reaching $44.74. 61,789 shares of the stock traded hands, compared to its average volume of 81,501. The company has a fifty day moving average of $46.54 and a 200 day moving average of $48.15. The stock has a market capitalization of $858.91 million, a P/E ratio of 13.94, a PEG ratio of 1.38 and a beta of 0.94. USANA Health Sciences, Inc. has a 12 month low of $41.45 and a 12 month high of $69.60.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. On average, analysts predict that USANA Health Sciences, Inc. will post 2.75 EPS for the current fiscal year.

Hedge Funds Weigh In On USANA Health Sciences

Several large investors have recently modified their holdings of USNA. Quest Partners LLC bought a new stake in shares of USANA Health Sciences during the 4th quarter valued at $66,000. CWM LLC increased its stake in USANA Health Sciences by 49.6% during the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after purchasing an additional 420 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in USANA Health Sciences by 60.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after buying an additional 1,274 shares during the last quarter. Trexquant Investment LP purchased a new position in shares of USANA Health Sciences in the 4th quarter valued at about $266,000. Finally, Teacher Retirement System of Texas acquired a new stake in USANA Health Sciences in the third quarter valued at approximately $297,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

Analysts Set New Price Targets

USNA has been the subject of several recent analyst reports. DA Davidson reduced their target price on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research note on Tuesday. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.